“In India, over half a million people living with HIV are on treatment but the best tool to monitor their treatment – the viral load test – is not easily accessible and available. Access to viral load testing is strictly rationed and is only available if the SACEP (State AIDS Clinical Expert Panel) committee – … Read more
New York/Paris, December 9, 2013—After deadly attacks and threats inside hospitals in the Central African Republic capital of Bangui, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today called on all parties to the conflict to allow the wounded and sick to safely obtain medical care, and for an end to violence … Read more
DECEMBER 7, 2013—Following violence in Bangui on December 5, hundreds of people are wounded, and thousands have fled, regrouping in several sites around the city. Doctors Without Borders/Médecins Sans Frontières (MSF) is expanding activities to continue to treat the wounded and provide health services to about 14,000 people in two of the main sites for … Read more
MSF Teams Treating Scores of Wounded in City Hospitals BANGUI, CENTRAL AFRICAN REPUBLIC, DECEMBER 5, 2013—Violent armed clashes in the Central African Republic (CAR) capital of Bangui early this morning caused dozens of casualties, including numerous deaths. Teams from the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) are working in city hospitals … Read more
Concerns over Global Fund-led changes to a model which enables affordable scale up of HIV treatment Geneva/New York, 2 December 2013 – Ahead of the Global Fund replenishment conference in Washington, DC this week, international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) has warned the Global Fund to Fight AIDS, Tuberculosis and Malaria … Read more
Johannesburg, November 25, 2013 — The fight against HIV/AIDS has been hailed as one of the most successful public health projects in human history, but teams from the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) see the revolution as unfulfilled for millions of people excluded from treatment. Today, MSF launches a film series titled … Read more
On November 22, 2013, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for delamanid, only the second new TB drug to be developed in 50 years. It is hoped that the new drug, marketed by the Japanese company Otsuka, will be pivotal in improving … Read more
‘Patent opposition’ seeks to ensure production of affordable generics November 22, 2013, New Delhi/New York: DoctorsWithout Borders/Médecins Sans Frontières (MSF) supports the ‘patent opposition’ just filed at India’s Patent Office by the Initiative for Medicines, Access & Knowledge (I-MAK), which aims to prevent US pharmaceutical company Gilead/Pharmasset from gaining a patent in India on sofosbuvir, … Read more
On November 22, 2013, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for delamanid, only the second new TB drug to be developed in 50 years. It is hoped that the new drug, marketed by the Japanese company Otsuka, will be pivotal in improving … Read more
New TB drug bedaquiline illustrates need for paradigm shift in developing and ensuring access to new treatment combinations. Paris, October 30, 2013: Without a new approach to developing and pricing new tuberculosis medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis … Read more